{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:34:16Z","timestamp":1770219256338,"version":"3.49.0"},"reference-count":39,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"NIH","award":["1K23 HL105568"],"award-info":[{"award-number":["1K23 HL105568"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1002\/pbc.24630","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T08:15:02Z","timestamp":1371543302000},"page":"1753-1758","source":"Crossref","is-referenced-by-count":23,"title":["Trends in blood transfusion among hospitalized children with sickle cell disease"],"prefix":"10.1002","volume":"60","author":[{"given":"Jean L.","family":"Raphael","sequence":"first","affiliation":[{"name":"Department of Pediatrics; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzette O.","family":"Oyeku","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Albert Einstein College of Medicine; Bronx New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Kowalkowski","sequence":"additional","affiliation":[{"name":"Department of Medicine; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitta U.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Ellison","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"10.1002\/pbc.24630-BIB0001|pbc24630-cit-0001","unstructured":"The Management of Sickle Cell Disease: National Institutes of Health: National Heart, Lung, and Blood Institute; 2002. Report. NIH Publication No. 02-2117"},{"key":"10.1002\/pbc.24630-BIB0002|pbc24630-cit-0002","first-page":"172","volume-title":"Cognitive aspects of chronic illness in children","author":"Frank","year":"1999"},{"key":"10.1002\/pbc.24630-BIB0003|pbc24630-cit-0003","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.1989.tb24156.x","article-title":"The natural history of sickle cell disease","volume":"565","author":"Smith","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1002\/pbc.24630-BIB0004|pbc24630-cit-0004","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1002\/pbc.24630-BIB0005|pbc24630-cit-0005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the patient with sickle cell disease: A critical review of the literature and transfusion guidelines","volume":"21","author":"Josephson","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1002\/pbc.24630-BIB0006|pbc24630-cit-0006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/08880018.2010.505506","article-title":"Transfusion and chelation practices in sickle cell disease: A regional perspective","volume":"28","author":"Vichinsky","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1002\/pbc.24630-BIB0007|pbc24630-cit-0007","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/pbc.24179","article-title":"Indications and complications of transfusions in sickle cell disease","volume":"59","author":"Smith-Whitley","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.24630-BIB0008|pbc24630-cit-0008","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.med.49.1.461","article-title":"New considerations in the treatment of sickle cell disease","volume":"49","author":"Reed","year":"1998","journal-title":"Annu Rev Med"},{"key":"10.1002\/pbc.24630-BIB0009|pbc24630-cit-0009","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1526-0968.2002.00425.x","article-title":"Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapheresis","volume":"6","author":"Nifong","year":"2002","journal-title":"Ther Apher"},{"key":"10.1002\/pbc.24630-BIB0010|pbc24630-cit-0010","first-page":"61","article-title":"Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood","volume":"30","author":"Thurston","year":"2004","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1002\/pbc.24630-BIB0011|pbc24630-cit-0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.21307\/immunohematology-2019-369","article-title":"Review: Clinical transfusion management in sickle cell disease","volume":"22","author":"Rogers","year":"2006","journal-title":"Immunohematology"},{"key":"10.1002\/pbc.24630-BIB0012|pbc24630-cit-0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0037-1963(01)90055-1","article-title":"Indications for red cell transfusion in sickle cell disease","volume":"38","author":"Ohene-Frempong","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1002\/pbc.24630-BIB0013|pbc24630-cit-0013","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24630-BIB0014|pbc24630-cit-0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOP.0b013e328321882e","article-title":"Current issues in blood transfusion for sickle cell disease","volume":"21","author":"Wahl","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1002\/pbc.24630-BIB0015|pbc24630-cit-0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.12061","article-title":"Challenges of alloimmunization in patients with haemoglobinopathies","volume":"159","author":"Chou","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.24630-BIB0016|pbc24630-cit-0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"10.1002\/pbc.24630-BIB0017|pbc24630-cit-0017","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0037-1963(01)90058-7","article-title":"Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease","volume":"38","author":"Ballas","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1002\/pbc.24630-BIB0018|pbc24630-cit-0018","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2141.2010.08451.x","article-title":"Blood transfusion usage among adults with sickle cell disease-A single institution experience over ten years","volume":"152","author":"Drasar","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.24630-BIB0019|pbc24630-cit-0019","unstructured":"Introduction to the HCUP KIDS Inpatient Database: Agency for Healthcare Research and Quality; 2008. Report http:\/\/www.hcup-us.ahrq.gov\/db\/nation\/kid\/kid_2006_introduction.jsp"},{"key":"10.1002\/pbc.24630-BIB0020|pbc24630-cit-0020","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24630-BIB0021|pbc24630-cit-0021","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pbc.24392","article-title":"National trends in incidence rates of hospitalization for stroke in children with sickle cell disease","volume":"60","author":"McCavit","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.24630-BIB0022|pbc24630-cit-0022","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1182\/blood-2010-11-261834","article-title":"How I treat acute chest syndrome in children with sickle cell disease","volume":"117","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"10.1002\/pbc.24630-BIB0023|pbc24630-cit-0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3928\/00904481-20130222-11","article-title":"A review of acute chest syndrome in pediatric sickle cell disease","volume":"42","author":"Abbas","year":"2013","journal-title":"Pediatr Ann"},{"key":"10.1002\/pbc.24630-BIB0024|pbc24630-cit-0024","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tmrv.2008.02.006","article-title":"Blood donation and blood transfusion: Special considerations for African Americans","volume":"22","author":"Shaz","year":"2008","journal-title":"Transfus Med Rev"},{"key":"10.1002\/pbc.24630-BIB0025|pbc24630-cit-0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1537-2995.2010.02775.x","article-title":"Contribution of attitudinal factors to blood donation in African American church attendees","volume":"51","author":"James","year":"2011","journal-title":"Transfusion"},{"key":"10.1002\/pbc.24630-BIB0026|pbc24630-cit-0026","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24630-BIB0027|pbc24630-cit-0027","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bpa.2007.01.002","article-title":"Estimating the cost of blood: Past, present, and future directions","volume":"21","author":"Shander","year":"2007","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1002\/pbc.24630-BIB0028|pbc24630-cit-0028","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.V96.7.2369","article-title":"Financial analysis of chronic transfusion for stroke prevention in sickle cell disease","volume":"96","author":"Wayne","year":"2000","journal-title":"Blood"},{"key":"10.1002\/pbc.24630-BIB0029|pbc24630-cit-0029","unstructured":"Steiner CA Miller JL Sickle cell disease patients in U.S. hospitals; 2004. HCUP statistical brief #21. December 2006 Rockville, MD Agency for Healthcare Research and Quality http:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb21.pdf"},{"key":"10.1002\/pbc.24630-BIB0030|pbc24630-cit-0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21307\/immunohematology-2019-368","article-title":"Transfusion support of patients with sickle cell disease at the Children's Hospital of Philadelphia","volume":"22","author":"Sesok-Pizzini","year":"2006","journal-title":"Immunohematology"},{"key":"10.1002\/pbc.24630-BIB0031|pbc24630-cit-0031","doi-asserted-by":"crossref","first-page":"108","DOI":"10.21307\/immunohematology-2019-365","article-title":"Partners for life: The transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia","volume":"22","author":"Hillyer","year":"2006","journal-title":"Immunohematology"},{"key":"10.1002\/pbc.24630-BIB0032|pbc24630-cit-0032","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1537-2995.2008.02009.x","article-title":"The Sickle Cell Sabbath: A community program increases first-time blood donors in the African American faith community","volume":"49","author":"Price","year":"2009","journal-title":"Transfusion"},{"key":"10.1002\/pbc.24630-BIB0033|pbc24630-cit-0033","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOH.0b013e32833e5ac7","article-title":"Minority donation in the United States: Challenges and needs","volume":"17","author":"Shaz","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1002\/pbc.24630-BIB0034|pbc24630-cit-0034","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajh.20809","article-title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload","volume":"82","author":"Fung","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1002\/pbc.24630-BIB0035|pbc24630-cit-0035","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2009-02-203323","article-title":"Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury","volume":"114","author":"Adamkiewicz","year":"2009","journal-title":"Blood"},{"key":"10.1002\/pbc.24630-BIB0036|pbc24630-cit-0036","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood.V96.1.76","article-title":"Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy","volume":"96","author":"Harmatz","year":"2000","journal-title":"Blood"},{"key":"10.1002\/pbc.24630-BIB0037|pbc24630-cit-0037","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/pbc.21929","article-title":"Oral iron chelation and the treatment of iron overload in a pediatric hematology center","volume":"52","author":"Raphael","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.24630-BIB0038|pbc24630-cit-0038","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.2006.06455.x","article-title":"A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease","volume":"136","author":"Vichinsky","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1002\/pbc.24630-BIB0039|pbc24630-cit-0039","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMct1004810","article-title":"Iron-chelating therapy for transfusional iron overload","volume":"364","author":"Brittenham","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24630","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24630","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pbc.24630\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T15:25:08Z","timestamp":1645802708000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.24630"}},"subtitle":["Transfusion in Sickle Cell Disease"],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.24630","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,18]]}}}